P110 Disparities of EGFR Mutations Between Biopsy and Rebiopsy in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients

Sveikatos mokslai
2016English

Rebiopsy of Histological Samples in Pretreated Non-Small Cell Lung Cancer: Comparison Among Rebiopsy Procedures

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2017English

P108 Distribution Characteristics and Response Analysis of Non-Small Cell Lung Cancer Patients With EGFR Rare Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2015English

HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Post-Progression Survival After EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

PLoS ONE
Multidisciplinary
2015English

OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations

OncoTargets and Therapy
OncologyPharmacology
2016English

EGFR and KRAS Mutations and Disease Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy